Karin Hellner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Karin Hellner has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
Hooman Soleymani Majd
Department of Gynaecology, Oxford University Hospitals, Oxford, UK
3 shared publicationsLucy Dorrell
Nuffield Department of Women’s and Reproductive Health, University of Oxford, Oxford, UK
2 shared publicationsAbhisek Ghosh
Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, England, UK
1 shared publication- Ahmed Ashour Ahmed
University of Oxford
1 shared publication - Ahmed Darwish
Nuffield Department of Women’s and Reproductive Health, University of Oxford, Oxford OX2 6GG, UK
1 shared publication - Alba Mota
Departamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), IdiPAZ, Madrid, Spain
1 shared publication
Latest Publications
- Open Access
- 11 May 2026
- Published by Springer Nature in npj Vaccines
- Vol. 11 (1)
Intranasal boosting enhances genital tract T cell immunity following ChAdOx1/MVA hrHPV therapeutic vaccination
High risk human papillomaviruses (hrHPV) infect mucosal epithelia and are the causative agents of cervical cancer. Prophylactic vaccines protect against disease caused by several, but not all hrHPV types. Furthermore, prophylactic vaccines are not widely available to populations with the greatest disease burden and have no therapeutic effect in previously infected individuals. Therapeutic vaccines that enhance host immunity in individuals with persistent hrHPV infections represents a promising strategy to support cervical cancer control. However, efficacy of a therapeutic vaccine depends not only on antigen selection and delivery system, but also on the route of immunisation. Because cervical intraepithelial lesions are confined to the genital mucosa, an effective therapeutic vaccine may need to elicit immune effector cells at the site of disease. Here we study the effect of immunisation route on vaccine immunogenicity using previously described ChAdOx1- and MVA-vectored hrHPV therapeutic vaccines encoding a multigenotype insert. In addition, we used GFP-expressing viral-vectored vaccines to monitor vaccine uptake in the cervix by real-time in vivo imaging. Among all regimens tested, the intramuscular prime–intranasal boost induced the highest magnitude of E6-specific CD8+ T cells in both the spleen and cervicovaginal compartment, and also generated the greatest frequency of cervicovaginal CD8+ TRM cells.
- 11 May 2026
- Published by Springer Nature in npj Vaccines
- Vol. 11 (1)
Open AccessIntranasal boosting enhances genital tract T cell immunity following ChAdOx1/MVA hrHPV therapeutic vaccination
High risk human papillomaviruses (hrHPV) infect mucosal epithelia and are the causative agents of cervical cancer. Prophylactic vaccines protect against disease caused by several, but not all hrHPV types. Furthermore, prophylactic vaccines are not widely available to populations with the greatest disease burden and have no therapeutic effect in previously infected individuals. Therapeutic vaccines that enhance host immunity in individuals with persistent hrHPV infections represents a promising strategy to support cervical cancer control. However, efficacy of a therapeutic vaccine depends not only on antigen selection and delivery system, but also on the route of immunisation. Because cervical intraepithelial lesions are confined to the genital mucosa, an effective therapeutic vaccine may need to elicit immune effector cells at the site of disease. Here we study the effect of immunisation route on vaccine immunogenicity using previously described ChAdOx1- and MVA-vectored hrHPV therapeutic vaccines encoding a multigenotype insert. In addition, we used GFP-expressing viral-vectored vaccines to monitor vaccine uptake in the cervix by real-time in vivo imaging. Among all regimens tested, the intramuscular prime–intranasal boost induced the highest magnitude of E6-specific CD8+ T cells in both the spleen and cervicovaginal compartment, and also generated the greatest frequency of cervicovaginal CD8+ TRM cells.
- Open Access
- 19 March 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (3) , e72327
Ectocervical Hypergranulation Secondary to Transcervical Coil Thread Perforation—An Unusual Cause for Persistent Postcoital Bleeding
Cervical perforation by coil threads is an uncommon complication. Predisposing factors may include prior cervical interventions, hypoestrogenic atrophy, thread material, and duration of use. Awareness is essential when evaluating abnormal bleeding or atypical thread presentation despite radiologically correct placement.
- 19 March 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (3) , e72327
Open AccessEctocervical Hypergranulation Secondary to Transcervical Coil Thread Perforation—An Unusual Cause for Persistent Postcoital Bleeding
Cervical perforation by coil threads is an uncommon complication. Predisposing factors may include prior cervical interventions, hypoestrogenic atrophy, thread material, and duration of use. Awareness is essential when evaluating abnormal bleeding or atypical thread presentation despite radiologically correct placement.
- 19 January 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (1) , e270886
Concomitant low-grade B-cell lymphoma and cervical intraepithelial neoplasia
Primary cervical lymphoma is a rare entity of cervical malignancy. The diagnostic pitfalls arise from the non-specific clinical presentation and poor sensitivity of cervical cytology in detecting the disease. Here, we present a case of extra-nodal marginal zone cervical lymphoma in a postmenopausal nulliparous woman. The patient underwent colposcopy due to an abnormal cervical smear and was found to have a large cervical lesion in keeping with high-grade cervical intraepithelial neoplasia (CIN). Cervical conisation was performed, and a low-grade B-cell lymphoma confined to the cervix was found underneath the surface CIN. As there was no established treatment for this uncommon disease, multidisciplinary involvement was required for optimal management and follow-up of the patient. The prognosis is generally favourable in comparison to the common cervical malignancies.
- 19 January 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (1) , e270886
Concomitant low-grade B-cell lymphoma and cervical intraepithelial neoplasia
Primary cervical lymphoma is a rare entity of cervical malignancy. The diagnostic pitfalls arise from the non-specific clinical presentation and poor sensitivity of cervical cytology in detecting the disease. Here, we present a case of extra-nodal marginal zone cervical lymphoma in a postmenopausal nulliparous woman. The patient underwent colposcopy due to an abnormal cervical smear and was found to have a large cervical lesion in keeping with high-grade cervical intraepithelial neoplasia (CIN). Cervical conisation was performed, and a low-grade B-cell lymphoma confined to the cervix was found underneath the surface CIN. As there was no established treatment for this uncommon disease, multidisciplinary involvement was required for optimal management and follow-up of the patient. The prognosis is generally favourable in comparison to the common cervical malignancies.
- 17 December 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83 (1) , 51-58
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-risk Human Papillomavirus Vaccine in Women With Low-grade Cervical Lesions
Background: The clearance of high-risk oncogenic human papillomaviruses (hrHPV) and related cervical lesions is associated with the development of a robust T-cell response. Therapeutic vaccination that induces HPV antigen-specific T cells is a promising approach. Method: A 2-vector dosing strategy using Chimpanzee Adenovirus Oxford 1-HPV and Modified Vaccinia virus Ankara-HPV, both encoding the same multiantigen HPV cassette was given on a 0/28-day schedule to participants with persistent cervical hrHPV and a history of low-grade cervical lesions. An open-label lead-in was followed by a randomized, blinded, placebo-controlled main phase. The primary endpoint was the safety of the different dose regimens; secondary endpoints included immunogenicity, and clearance of hrHPV and associated lesions at 12 months. Nine participants were enrolled in the lead-in and 99 were randomized 67:32 to 5 active dose arms or placebo, respectively. Results: The regimens were well-tolerated with no grade 3–related treatment emergent adverse events or serious adverse reactions. All dosing regimens generated antigen-specific CD4+ and CD8+ T-cell responses. There was no difference in hrHPV clearance between the pooled active groups and placebo (20/64 [31.3%] versus 10/30 [33.3%]; P > .99), nor in lesion clearance. A trend toward higher hrHPV clearance (60%) was observed with the highest Chimpanzee Adenovirus Oxford 1-HPV doses. No association between the peripheral immune response and clearance was demonstrated. Conclusions: A heterologous, multiantigenic HPV 2-component immunotherapy regimen was well-tolerated and immunogenic but did not result in a statistically significant clearance of either hrHPV or the associated cervical lesions in women with persistent high-risk HPV infections. Trial registration: EudraCT 2019-001890-98; NCT04607850
- 17 December 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83 (1) , 51-58
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-risk Human Papillomavirus Vaccine in Women With Low-grade Cervical Lesions
Background: The clearance of high-risk oncogenic human papillomaviruses (hrHPV) and related cervical lesions is associated with the development of a robust T-cell response. Therapeutic vaccination that induces HPV antigen-specific T cells is a promising approach. Method: A 2-vector dosing strategy using Chimpanzee Adenovirus Oxford 1-HPV and Modified Vaccinia virus Ankara-HPV, both encoding the same multiantigen HPV cassette was given on a 0/28-day schedule to participants with persistent cervical hrHPV and a history of low-grade cervical lesions. An open-label lead-in was followed by a randomized, blinded, placebo-controlled main phase. The primary endpoint was the safety of the different dose regimens; secondary endpoints included immunogenicity, and clearance of hrHPV and associated lesions at 12 months. Nine participants were enrolled in the lead-in and 99 were randomized 67:32 to 5 active dose arms or placebo, respectively. Results: The regimens were well-tolerated with no grade 3–related treatment emergent adverse events or serious adverse reactions. All dosing regimens generated antigen-specific CD4+ and CD8+ T-cell responses. There was no difference in hrHPV clearance between the pooled active groups and placebo (20/64 [31.3%] versus 10/30 [33.3%]; P > .99), nor in lesion clearance. A trend toward higher hrHPV clearance (60%) was observed with the highest Chimpanzee Adenovirus Oxford 1-HPV doses. No association between the peripheral immune response and clearance was demonstrated. Conclusions: A heterologous, multiantigenic HPV 2-component immunotherapy regimen was well-tolerated and immunogenic but did not result in a statistically significant clearance of either hrHPV or the associated cervical lesions in women with persistent high-risk HPV infections. Trial registration: EudraCT 2019-001890-98; NCT04607850
- Open Access
Acceptability of diagnostic tampon self-sampling for HPV: Mixed methods findings from the STAMP Trial and focus groups
Background Multiple barriers limit access to traditional in-person clinician sampling for cervical cancer. The STAMP (Screening with Tampons: Evaluating Diagnostic Accuracy for HPV and Assessing Participant Views) study evaluated the diagnostic accuracy and acceptability of tampon-based self-sampling for HPV amongst people assigned female at birth. Encouraging technical performance of the tampon as a sample for microbial detection was observed relative to clinician-taken samples. Pre and post trial questionnaires and a nested qualitative study explored acceptability. Methods All participants (n=263) completed questionnaires before and after sampling using three methods: tampon-based self-sampling, swab-based self-sampling, and clinician-collected samples. Questions included comfort, trust and ease of use of tampon-sampling. Four focus groups (n=24) were conducted online, and analysed using reflexive thematic analysis. Results Questionnaire responses suggested tampon-based self-sampling was highly acceptable. Qualitative analysis identified four key themes: advantages of self-sampling over clinician-sampling; unique benefits of tampon-based self-sampling; concerns about accuracy and trust; and confidence in correct use. Participants valued the physical comfort, psychological ease, and practical convenience of self-sampling compared to clinician-sampling. The familiarity of tampons as an everyday product was central to acceptability, normalising screening. While some initially questioned accuracy, most were reassured by evidence of performance. Clear instructions and understanding the evidence base boosted confidence. Conclusion Findings suggest that tampon-based self-sampling is a highly acceptable alternative sampling approach for cervical screening that may increase screening participation by addressing multiple barriers. Implementation strategies should emphasise the method’s everyday nature, while providing accessible guidance to support correct usage. What is already known on this topic Self-sampling for Human Papillomavirus (HPV) has been recommended by the World Health Organisation as an additional approach to expand cervical cancer screening services, complementing conventional clinician-taken sampling to broaden access and address barriers associated with in-person care. What this study adds Findings from this study suggest that self-sampling has the potential to support screening for cervical cancer as an acceptable, at-home approach addressing physical, psychological and practical barriers associated with traditional clinician collected sampling. Participants reported that the familiarity of using a tampon for self-sampling creates a unique advantage over other self-sampling methods through demedicalising and normalising screening, therefore potentially increasing accessibility and participation among underscreened populations who experience most barriers. How this study might affect research, practice or policy Self-sampling including tampon-based self sampling offers a promising, acceptable approach to achieving cancer elimination goals. Implementation of tampon-based self-sampling for HPV should be clear, comprehensive and accessible, incorporating visual aids and simple language while emphasising the rationale and scientific evidence behind the collection method
Open AccessAcceptability of diagnostic tampon self-sampling for HPV: Mixed methods findings from the STAMP Trial and focus groups
Background Multiple barriers limit access to traditional in-person clinician sampling for cervical cancer. The STAMP (Screening with Tampons: Evaluating Diagnostic Accuracy for HPV and Assessing Participant Views) study evaluated the diagnostic accuracy and acceptability of tampon-based self-sampling for HPV amongst people assigned female at birth. Encouraging technical performance of the tampon as a sample for microbial detection was observed relative to clinician-taken samples. Pre and post trial questionnaires and a nested qualitative study explored acceptability. Methods All participants (n=263) completed questionnaires before and after sampling using three methods: tampon-based self-sampling, swab-based self-sampling, and clinician-collected samples. Questions included comfort, trust and ease of use of tampon-sampling. Four focus groups (n=24) were conducted online, and analysed using reflexive thematic analysis. Results Questionnaire responses suggested tampon-based self-sampling was highly acceptable. Qualitative analysis identified four key themes: advantages of self-sampling over clinician-sampling; unique benefits of tampon-based self-sampling; concerns about accuracy and trust; and confidence in correct use. Participants valued the physical comfort, psychological ease, and practical convenience of self-sampling compared to clinician-sampling. The familiarity of tampons as an everyday product was central to acceptability, normalising screening. While some initially questioned accuracy, most were reassured by evidence of performance. Clear instructions and understanding the evidence base boosted confidence. Conclusion Findings suggest that tampon-based self-sampling is a highly acceptable alternative sampling approach for cervical screening that may increase screening participation by addressing multiple barriers. Implementation strategies should emphasise the method’s everyday nature, while providing accessible guidance to support correct usage. What is already known on this topic Self-sampling for Human Papillomavirus (HPV) has been recommended by the World Health Organisation as an additional approach to expand cervical cancer screening services, complementing conventional clinician-taken sampling to broaden access and address barriers associated with in-person care. What this study adds Findings from this study suggest that self-sampling has the potential to support screening for cervical cancer as an acceptable, at-home approach addressing physical, psychological and practical barriers associated with traditional clinician collected sampling. Participants reported that the familiarity of using a tampon for self-sampling creates a unique advantage over other self-sampling methods through demedicalising and normalising screening, therefore potentially increasing accessibility and participation among underscreened populations who experience most barriers. How this study might affect research, practice or policy Self-sampling including tampon-based self sampling offers a promising, acceptable approach to achieving cancer elimination goals. Implementation of tampon-based self-sampling for HPV should be clear, comprehensive and accessible, incorporating visual aids and simple language while emphasising the rationale and scientific evidence behind the collection method
- Open Access
- 11 January 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (2) , 580
Modelling Endometriosis Using In Vitro and In Vivo Systems
Endometriosis is a chronic inflammatory condition characterised by the presence of endometrium-like tissue outside the uterus. Despite its high prevalence and recent advances in molecular science, many aspects of endometriosis and its pathophysiology are still poorly understood. Previously, in vitro and in vivo modelling have been instrumental in establishing our current understanding of endometriosis. As the field of molecular science and the advance towards personalised medicine is ever increasing, more sophisticated models are continually being developed. These hold great potential to provide more intricate knowledge of the underlying pathophysiology and facilitate investigations into potential future approaches to diagnosis and treatment. This review provides an overview of different in vitro and in vivo models of endometriosis that are pertinent to establishing our current understanding. Moreover, we discuss new cross-cutting approaches to endometriosis modelling, such as the use of microfluidic cultures and 3D printing, which have the potential to shape the future of endometriosis research.
- 11 January 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (2) , 580
Open AccessModelling Endometriosis Using In Vitro and In Vivo Systems
Endometriosis is a chronic inflammatory condition characterised by the presence of endometrium-like tissue outside the uterus. Despite its high prevalence and recent advances in molecular science, many aspects of endometriosis and its pathophysiology are still poorly understood. Previously, in vitro and in vivo modelling have been instrumental in establishing our current understanding of endometriosis. As the field of molecular science and the advance towards personalised medicine is ever increasing, more sophisticated models are continually being developed. These hold great potential to provide more intricate knowledge of the underlying pathophysiology and facilitate investigations into potential future approaches to diagnosis and treatment. This review provides an overview of different in vitro and in vivo models of endometriosis that are pertinent to establishing our current understanding. Moreover, we discuss new cross-cutting approaches to endometriosis modelling, such as the use of microfluidic cultures and 3D printing, which have the potential to shape the future of endometriosis research.
- 4 January 2025
- Published by Elsevier in The Lancet
- Vol. 405 (10472) , 70
Postcoital bleeding in a 26-year-old woman: a rare case of a cervical capillary haemangioma
- 4 January 2025
- Published by Elsevier in The Lancet
- Vol. 405 (10472) , 70
Postcoital bleeding in a 26-year-old woman: a rare case of a cervical capillary haemangioma
- Open Access
- 16 December 2024
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 57, 101663
Cervicitis decidualis mimicking cervical cancer in pregnancy
- 16 December 2024
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 57, 101663
Open AccessCervicitis decidualis mimicking cervical cancer in pregnancy
- Open Access
- 1 July 2024
- Published by Bioscientifica in Reproduction and Fertility
- Vol. 5 (3)
Elevated basophil count is associated with increased odds of endometriosis
Graphical Immunological dysregulation plays a fundamental role in the inflammatory aspects of endometriosis. Circulating blood leukocytes, one of the most abundant immune cell populations in the human body, have been shown diagnostic significance in some diseases. Nevertheless, the association between peripheral blood leukocyte counts and endometriosis remains unexplored to date. We analyzed two targeted study cohorts: a tertiary center cohort (Endometriosis at Oxford University (ENDOX) Study: 325 cases/177 controls) and a large-scale population study (UK Biobank (UKBB): 1537 cases/6331 controls). In both datasets, peripheral venous blood sample results were retrieved, and counts of leukocyte subpopulations, including neutrophils, lymphocytes, monocytes, eosinophils, and basophils, were analyzed. Logistic regression models were used to investigate the association of leukocyte subtype alterations with endometriosis status, adjusting for confounding factors. We demonstrate that a higher blood basophil level is associated with increased odds of endometriosis. This association was first discovered in the ENDOX cohort (basophils >0.04 × 109/L: OR 1.65 (95% CI: 1.06–2.57), Ptrend = 0.025) and replicated in the UKBB dataset (basophils >0.04 × 109/L: OR 1.26 (95% CI: 1.09–1.45), Ptrend = 0.001). Notably, women with basophil counts in the upper tercile had significantly increased odds of having stage III/IV endometriosis (ENDOX study: OR = 2.30, 95% CI (1.25–4.22), Ptrend = 0.007; UKBB study (OR = 1.40, 95% CI (1.07–1.85), Ptrend = 0.015). None of the other leukocyte subtypes showed an association. Our findings suggest an association between inflammatory responses and the pathogenesis of endometriosis; future studies are warranted to investigate whether the association is causal. Lay summary: Endometriosis is a long-term disease affecting approximately 10% of women during their fertile age. It happens when the tissue similar to the lining of the womb grows in other parts of the body, commonly causing pelvic pain and subfertility. Most diagnostic tests for endometriosis are neither accurate nor reliable, leading to a long wait before a correct diagnosis. Looking for changes in blood cell counts could guide doctors for further testing to confirm diagnosis. Our study shows that a higher number of basophils, a specialized type of white cells, commonly measured in a simple blood test, are positively linked with a higher likelihood of endometriosis. The link becomes stronger in severe endometriosis cases. Although we are showing a robust link, whether this can be used to find endometriosis sooner needs to be tested in future studies.
- 1 July 2024
- Published by Bioscientifica in Reproduction and Fertility
- Vol. 5 (3)
Open AccessElevated basophil count is associated with increased odds of endometriosis
Graphical Immunological dysregulation plays a fundamental role in the inflammatory aspects of endometriosis. Circulating blood leukocytes, one of the most abundant immune cell populations in the human body, have been shown diagnostic significance in some diseases. Nevertheless, the association between peripheral blood leukocyte counts and endometriosis remains unexplored to date. We analyzed two targeted study cohorts: a tertiary center cohort (Endometriosis at Oxford University (ENDOX) Study: 325 cases/177 controls) and a large-scale population study (UK Biobank (UKBB): 1537 cases/6331 controls). In both datasets, peripheral venous blood sample results were retrieved, and counts of leukocyte subpopulations, including neutrophils, lymphocytes, monocytes, eosinophils, and basophils, were analyzed. Logistic regression models were used to investigate the association of leukocyte subtype alterations with endometriosis status, adjusting for confounding factors. We demonstrate that a higher blood basophil level is associated with increased odds of endometriosis. This association was first discovered in the ENDOX cohort (basophils >0.04 × 109/L: OR 1.65 (95% CI: 1.06–2.57), Ptrend = 0.025) and replicated in the UKBB dataset (basophils >0.04 × 109/L: OR 1.26 (95% CI: 1.09–1.45), Ptrend = 0.001). Notably, women with basophil counts in the upper tercile had significantly increased odds of having stage III/IV endometriosis (ENDOX study: OR = 2.30, 95% CI (1.25–4.22), Ptrend = 0.007; UKBB study (OR = 1.40, 95% CI (1.07–1.85), Ptrend = 0.015). None of the other leukocyte subtypes showed an association. Our findings suggest an association between inflammatory responses and the pathogenesis of endometriosis; future studies are warranted to investigate whether the association is causal. Lay summary: Endometriosis is a long-term disease affecting approximately 10% of women during their fertile age. It happens when the tissue similar to the lining of the womb grows in other parts of the body, commonly causing pelvic pain and subfertility. Most diagnostic tests for endometriosis are neither accurate nor reliable, leading to a long wait before a correct diagnosis. Looking for changes in blood cell counts could guide doctors for further testing to confirm diagnosis. Our study shows that a higher number of basophils, a specialized type of white cells, commonly measured in a simple blood test, are positively linked with a higher likelihood of endometriosis. The link becomes stronger in severe endometriosis cases. Although we are showing a robust link, whether this can be used to find endometriosis sooner needs to be tested in future studies.